litlas
ログインアカウント作成

Thierry Naas

1991–2025 年に発表

178
論文数
23,913
被引用数
79
h 指数
170
i10 指数

被引用数

Thierry Naas の年別被引用数1990 年: 被引用 1 件1992 年: 被引用 7 件1993 年: 被引用 4 件1994 年: 被引用 12 件1995 年: 被引用 21 件1996 年: 被引用 18 件1997 年: 被引用 36 件1998 年: 被引用 54 件1999 年: 被引用 61 件2000 年: 被引用 86 件2001 年: 被引用 120 件2002 年: 被引用 133 件2003 年: 被引用 121 件2004 年: 被引用 117 件2005 年: 被引用 126 件2006 年: 被引用 138 件2007 年: 被引用 127 件2008 年: 被引用 145 件2009 年: 被引用 177 件2010 年: 被引用 236 件2011 年: 被引用 264 件2012 年: 被引用 287 件2013 年: 被引用 286 件2014 年: 被引用 257 件2015 年: 被引用 246 件2016 年: 被引用 236 件2017 年: 被引用 209 件2018 年: 被引用 142 件2019 年: 被引用 697 件2020 年: 被引用 786 件2021 年: 被引用 789 件2022 年: 被引用 731 件2023 年: 被引用 513 件2024 年: 被引用 866 件2025 年: 被引用 428 件2026 年: 被引用 11 件1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,574 件、この内訳の 17.4%フランス: 引用元論文 706 件、この内訳の 7.8%中国: 引用元論文 618 件、この内訳の 6.8%イギリス: 引用元論文 562 件、この内訳の 6.2%イタリア: 引用元論文 431 件、この内訳の 4.8%スペイン: 引用元論文 378 件、この内訳の 4.2%ドイツ: 引用元論文 333 件、この内訳の 3.7%インド: 引用元論文 252 件、この内訳の 2.8%オーストラリア: 引用元論文 238 件、この内訳の 2.6%カナダ: 引用元論文 218 件、この内訳の 2.4%スイス: 引用元論文 204 件、この内訳の 2.3%日本: 引用元論文 186 件、この内訳の 2.1%
0%17.4%その他 36.9%

機関

分野

  • Biochemistry, Genetics and Molecular Biology73.3%
  • Agricultural and Biological Sciences8.6%
  • Medicine7.9%
  • Immunology and Microbiology4.9%
  • Environmental Science2.8%
  • Engineering0.8%
  • その他1.7%

トピック

  • Antibiotic Resistance in Bacteria24.3%
  • Antibiotics Pharmacokinetics and Efficacy6.6%
  • Antibiotic Use and Resistance5%
  • Pharmaceutical and Antibiotic Environmental Impacts4.9%
  • Bacterial Identification and Susceptibility Testing4.7%
  • Bacterial biofilms and quorum sensing3.6%
  • その他50.9%

共著者

全論文

検索で開く
  1. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

    著者: Matteo Bassetti, Roger Echols, Yuko Matsunaga, Mari Ariyasu, Yohei Doi, Ricard Ferrer, Thomas P. Lodise, Thierry Naas, Yoshihito Niki, David L. Paterson, Simon Portsmouth, Julián Torre‐Cisneros, Kiichiro Toyoizumi, Richard G. Wunderink, Tsutae Den Nagata - The Lancet Infectious Diseases 2020 被引用: 792

  2. Beta-lactamase database (BLDB) – structure and function

    著者: Thierry Naas, Saoussen Oueslati, Rémy A. Bonnin, Maria Laura Dabos, Agustín Jacinto Zavala, Laurent Dortet, Pascal Retailleau, Bogdan I. Iorga - Journal of Enzyme Inhibition and Medicinal Chemistry 2017 被引用: 686

  3. Global Spread of Carbapenemase-producingEnterobacteriaceae

    著者: Patrice Nordmann, Thierry Naas, Laurent Poirel - Emerging infectious diseases 2011 被引用: 2,326

  4. Antimicrobial Peptides: A Potent Alternative to Antibiotics

    著者: Mariam Rima, Mohamad Rima, Ziad Fajloun, Jean‐Marc Sabatier, Burkhard Bechinger, Thierry Naas - Antibiotics 2021 被引用: 336

  5. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee

    著者: M.J. Ellington, Oskar Ekelund, Frank M. Aarestrup, Rafael Cantón, Michel Doumith, Christian G. Giske, H. Grundman, Henrik Hasman, Matthew T. G. Holden, Katie L. Hopkins, Jonathan R. Iredell, Gunnar Kahlmeter, Claudio U. Köser, Alasdair MacGowan, Dik Mevius, M. R. Mulvey, Thierry Naas, Tim Peto, Jean‐Marc Rolain, Ørjan Samuelsen, Neil Woodford - Clinical Microbiology and Infection 2016 被引用: 579

  6. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

    著者: Patrice Nordmann, Gaëlle Cuzon, Thierry Naas - The Lancet Infectious Diseases 2009 被引用: 1,582

  7. Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group

    著者: Antonio Oliver, Estrella Rojo‐Molinero, Jorge Arca-Suárez, Yeşim Besli, Pierre Bogaerts, Rafael Cantón, Cansu Çimen, P Croughs, Olivier Denis, Christian G. Giske, Tíscar Graells, Te‐Din Huang, Bogdan I. Iorga, Onur Karatuna, Béla Kocsis, Andreas Kronenberg, Carla López-Causapé, Surbhi Malhotra‐Kumar, Luis Martínez‐Martínez, Annarita Mazzariol, Sylvain Meyer, Thierry Naas, Daan W. Notermans, Jesús Oteo, Torunn Pedersen, Mateja Pirš, Patrícia Poeta, Laurent Poirel, Spyros Pournaras, Arnfinn Sundsfjord, Dóra Szabó, Arjana Tambić-Andrašević, Rossitza Vatcheva-Dobrevska, Astra Vitkauskienė, Katy Jeannot - Clinical Microbiology and Infection 2023 被引用: 94

  8. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

    著者: Rafael Cantón, Murat Akova, Yehuda Carmeli, Christian G. Giske, Y. Glupczynski, Marek Gniadkowski, David M. Livermore, Vivì Miriagou, Thierry Naas, Gian María Rossolini, Ørjan Samuelsen, Harald Seifert, Neil Woodford, Patrice Nordmann - Clinical Microbiology and Infection 2012 被引用: 881

  9. Diversity, Epidemiology, and Genetics of Class D β-Lactamases

    著者: Laurent Poirel, Thierry Naas, Patrice Nordmann - Antimicrobial Agents and Chemotherapy 2009 被引用: 614

  10. Worldwide Dissemination of theblaOXA-23Carbapenemase Gene ofAcinetobacter baumannii1

    著者: Pauline Mugnier, Laurent Poirel, Thierry Naas, Patrice Nordmann - Emerging infectious diseases 2009 被引用: 415

  11. Escherichia coli: an old friend with new tidings

    著者: Jordi Vilà, Emma Sáez-López, James R. Johnson, Ute Römling, Ulrich Dobrindt, Rafael Cantón, Christian G. Giske, Thierry Naas, Alessandra Carattoli, Margarita Martínez-Medina, Jordi Bosch, Pilar Retamar, Jesús Rodríguez‐Baño, Fernando Baquero, Sara M. Soto - FEMS Microbiology Reviews 2016 被引用: 334

  12. Clinical bacteriology in low-resource settings: today's solutions

    著者: Sien Ombelet, Jean‐Baptiste Ronat, Timothy R. Walsh, Cédric P. Yansouni, Janneke Cox, Erika Vlieghe, Delphine Martiny, Makeda Semret, Olivier Vandenberg, Jan Jacobs, Octavie Lunguya, Marie-France Phoba, Palpouguini Lompo, Thong Phe, Samuel Kariuki, Paul N. Newton, David A. B. Dance, Claude Mambo Muvunyi, Sayda El Safi, Barbara Barbé, Dadi Falay, Dissou Affolabi, Maurice PAGE, Céline Langendorf, Y. Gille, Tjalling Leenstra, John Stelling, Thierry Naas, Thomas Kesteman, Daniel Seifu, Elisabeth Delarocque‐Astagneau, Constance Schultsz, Heidi Schütt‐Gerowitt, Joanne Letchford, Heiman Wertheim, Gunnar Kahlmeter, Awa Kane - The Lancet Infectious Diseases 2018 被引用: 200

  13. Genetics of Acquired Antibiotic Resistance Genes in Proteus spp.

    著者: Delphine Girlich, Rémy A. Bonnin, Laurent Dortet, Thierry Naas - Frontiers in Microbiology 2020 被引用: 182

  14. Functional Characterization of Tn 4401 , a Tn 3 -Based Transposon Involved in bla KPC Gene Mobilization

    著者: Gaëlle Cuzon, Thierry Naas, Patrice Nordmann - Antimicrobial Agents and Chemotherapy 2011 被引用: 218

  15. High Frequency Retrotransposition in Cultured Mammalian Cells

    著者: John V. Moran, Susan E. Holmes, Thierry Naas, Ralph J. DeBerardinis, Jef D. Boeke, Haig H. Kazazian - Cell 1996 被引用: 1,043

  16. A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae

    著者: Hervé Boutal, Anaïs Vogel, Sandrine Bernabeu, Karine Devilliers, Elodie Creton, Garence Cotellon, Marc Plaisance, Saoussen Oueslati, Laurent Dortet, Agnès B. Jousset, Stéphanie Simon, Thierry Naas, Hervé Volland - Journal of Antimicrobial Chemotherapy 2017 被引用: 222

  17. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales

    著者: Rémy A. Bonnin, Cécile Emeraud, Agnès B. Jousset, Thierry Naas, Laurent Dortet - Clinical Microbiology and Infection 2022 被引用: 73

  18. Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales

    著者: Keith S. Kaye, Thierry Naas, Jason M. Pogue, Gian María Rossolini - Infectious Diseases and Therapy 2023 被引用: 57

  19. Genetic Structures at the Origin of Acquisition of the β-Lactamase bla KPC Gene

    著者: Thierry Naas, Gaëlle Cuzon, María Virginia Villegas, Marie-Frédérique Lartigue, John P. Quinn, Patrice Nordmann - Antimicrobial Agents and Chemotherapy 2008 被引用: 534

  20. All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies

    著者: Thomas P. Lodise, Matteo Bassetti, Ricard Ferrer, Thierry Naas, Yoshihito Niki, David L. Paterson, Markus Zeitlinger, Roger Echols - Expert Review of Anti-infective Therapy 2021 被引用: 58

  21. In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations

    著者: Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D. Perry, Mathias W. Pletz, Stefania Stefani, Ian Morrissey, Christopher Longshaw, ARTEMIS Study Investigators, Birgit Willinger, David Leyssene, C. Cattoën, Corentine Alauzet, Pierre Boyer, Véronique Dubois, Katy Jeannot, Stéphane Corvec, Jean‐Philippe Lavigne, Thomas Guillard, Audrey Merens Gontier, Thierry Naas, Holger Rohde, Stefan Ziesing, Can Imirzalioglu, Klaus‐Peter Hunfeld, Jette Jung, Sören Gatermann, Mathias W. Pletz, Gabriele Bianco, Anna Giammanco, Davide Carcione, Giammarco Raponi, Caterina Matinato, Enea Gino Di Domenico, Paolo Gaibani, Anna Marchese, Fabio Arena, Claudia Niccolai, Stefania Stefani, Cristina Pitart, José Luís González Barrios, Emilia Cercenado, Germán Bou, Alicia Beteta López, Rafael Cantón, Jose Lopez Hontangas, Irene Gracia-Ahufinger, Antonio Oliver, Lorena López‐Cerero, Nieves Larrosa, David W. Wareham, John D. Perry, Anna Casey, Jasvir Nahl, Daniel Hughes, Michael J. Coyne, Michelle M. Lister, Marie Attwood - Microbiology Spectrum 2024 被引用: 32

  22. Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales

    著者: Rémy A. Bonnin, Agnès B. Jousset, Cécile Emeraud, Saoussen Oueslati, Laurent Dortet, Thierry Naas - Frontiers in Medicine 2021 被引用: 92

  23. The Revolution of Lateral Flow Assay in the Field of AMR Detection

    著者: Hervé Boutal, Christian Moguet, Lilas Pommiès, Stéphanie Simon, Thierry Naas, Hervé Volland - Diagnostics 2022 被引用: 40

  24. Biochemical Characterization of the Naturally Occurring Oxacillinase OXA-50 ofPseudomonas aeruginosa

    著者: Delphine Girlich, Thierry Naas, Patrice Nordmann - Antimicrobial Agents and Chemotherapy 2004 被引用: 203